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“Cold turkey” works best  
for smoking cessation
Counsel patients who want to quit smoking that doing 
so abruptly leads to higher cessation rates than does 
quitting gradually. 
PRACTICE CHANGER 
Counsel patients who want to quit smoking 
that abrupt smoking cessation is more effec-
tive for long-term abstinence than taking a 
gradual approach.
STRENGTH OF RECOMMENDATION
B: Based on one well-designed, randomized 
controlled trial.
Lindson-Hawley N, Banting M, West R, et al. Gradual versus abrupt 
smoking cessation: a randomized, controlled noninferiority trial. Ann 
Intern Med. 2016;164:585-592.1
ILLUSTRATIVE CASE
A 43-year-old man has a 35-pack-year smoking 
history and currently smokes a pack of ciga-
rettes a day. He is eager to quit smoking after 
recently learning that a close friend of his has 
been diagnosed with lung cancer. He asks you 
whether he should quit “cold turkey” or grad-
ually. What would you recommend?
Between 2013 and 2014, one in 5 Amer-ican adults reported using tobacco products some days or every day, and 
66% of smokers in 2013 made at least one 
attempt to quit.2,3 The risks of tobacco use and 
the benefits of cessation are well established, 
and behavioral and pharmacologic interven-
tions both alone and in combination increase 
smoking cessation rates.4 The US Preventive 
Services Task Force recommends that health 
care providers address tobacco use and ces-
sation with patients at regular office visits and 
offer behavioral and pharmacologic interven-
tions.5 Current guidelines, however, make no 
specific recommendations regarding gradual 
vs abrupt smoking cessation methods.5 
A previous Cochrane review of 10 ran-
domized controlled trials demonstrated no 
significant difference in quit rates between 
gradual cigarette reduction leading up to a 
designated quit day and abrupt cessation. 
The meta-analysis was limited, however, by 
differences in patient populations, outcome 
definitions, and types of interventions (both 
pharmacologic and behavioral).6 
In a retrospective cohort study, French 
investigators reviewed an online database of 
62,508 smokers who presented to nationwide 
cessation services. The researchers found 
that older participants (≥45 years of age) and 
heavy smokers (≥21 cigarettes/d) were more 
likely to quit gradually than abruptly.7
STUDY SUMMARY
Quitting “cold turkey” is better  
than gradual cessation at 6 months
Lindson-Hawley, et al, conducted a ran-
domized, controlled, non-inferiority trial in 
England to assess if gradual cessation is as 
successful as abrupt cessation as a means of 
quitting smoking.1 The primary outcome was 
abstinence from smoking at 4 weeks, assessed 
using the Russell Standard, a set of 6 standard 
criteria (including validation by exhaled car-
bon monoxide concentrations of <10 ppm) 
used by the National Centre for Smoking Ces-
sation and Training to decrease variability of 
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reported smoking cessation rates in English 
studies.8 
Study participants were recruited via let-
ters from their primary care practice inviting 
them to call the researchers if they were inter-
ested in participating in a smoking cessation 
study. Almost 1100 people inquired about the 
study. In the end, 697 were randomized to 
either the abrupt-cessation group (n=355) or 
the gradual-cessation group (n=342). Base-
line characteristics between the 2 groups 
were similar.
All participants were asked to schedule a 
quit date for 2 weeks after their enrollment. 
Patients randomized to the gradual-cessation 
group were provided nicotine replacement 
patches (21 mg/d) and their choice of short-
acting nicotine replacement therapy (NRT) 
(gum, lozenges, nasal spray, sublingual tab-
lets, inhalator, or mouth spray) to use in the 
2 weeks leading up to the quit date, along 
with instructions to reduce smoking by half 
of the baseline amount by the end of the first 
week, and to a quarter of baseline by the end 
of the second week. 
Patients randomized to the abrupt-
cessation group were instructed to continue 
their current smoking habits until the ces-
sation date; during those 2 weeks they were 
given nicotine patches (because the other 
group received them and some evidence sug-
gests that precessation NRT increases quit 
rates), but no short-acting NRT. 
Following the cessation date, treat-
ment in both groups was identical, including 
behavioral support, 21 mg/d nicotine patches, 
and the participant’s choice of short-acting 
NRT. Behavioral support consisted of visits 
with a research nurse at the patient’s primary 
care practice weekly for 2 weeks before the 
quit date, the day before the quit date, weekly 
for 4 weeks after the quit date, and 8 weeks 
after the quit date. 
The chosen non-inferiority margin was 
equal to a relative risk (RR) of 0.81 (19% 
reduction in effectiveness) of quitting grad-
ually compared with abrupt cessation of 
smoking. Quit rates in the gradual-reduction 
group did not reach the threshold for non-
inferiority; in fact, 4-week abstinence was sig-
nificantly more likely in the abrupt-cessation 
group (49%) than in the gradual-cessation 
group (39.2%) (RR=0.80; 95% confidence 
interval [CI], 0.66-0.93; number needed to 
treat [NNT]=10). Similarly, secondary out-
comes of 8-week and 6-month abstinence 
rates showed superiority of abrupt over 
gradual cessation. At 6 months after the quit 
date, 15.5% of the gradual-cessation group 
and 22% of the abrupt-cessation group 
remained abstinent (RR=0.71; 95% CI, 0.46-
0.91; NNT=15). 
Patients’ preferred method  
of cessation plays a role 
The investigators also found a difference in 
successful cessation based on the partici-
pants preferred method of cessation. Partici-
pants who preferred abrupt cessation were 
more likely to be abstinent at 4 weeks than 
participants who preferred gradual cessation 
(52.2% vs 38.3%; P=.007). 
Patients with a baseline preference for 
gradual cessation were equally as likely to suc-
cessfully quit when allocated to abrupt ces-
sation against their preference as when they 
were allocated to gradual cessation: 4-week 
abstinence was seen in 34.6% of patients 
who preferred gradual cessation and were 
allocated to gradual cessation and in 42% of 
patients who preferred gradual cessation but 
were allocated to abrupt cessation (P=.152).
WHAT’S NEW
Higher quality than previous studies  
and added element of preference
This large, well-designed, non-inferiority 
study showed that abrupt cessation is 
superior to gradual cessation. The size and 
design of the study, including a standardized 
method of assessing cessation and a standard-
ized intervention, make this a higher quality 
study than those in the Cochrane meta-anal-
ysis.6 This study also showed that participants 
who preferred gradual cessation were less 
likely to be successful—regardless of the meth-
od to which they were ultimately randomized. 
CAVEATS
Generalizability limited by race  
and number of cigarettes smoked
Patients lost to follow-up at 4 weeks (35 in 
People who 
prefer gradual 
cessation  
are less likely 
to be successful 
at quitting—
regardless of 
whether they try 
to quit abruptly 
or gradually.
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the abrupt-cessation group and 48 in the 
gradual-cessation group) were assumed to 
have continued smoking, which may have 
biased the results toward abrupt cessation. 
That said, the large number of participants 
included in the study, along with the relatively 
small number of patients lost to follow-up, 
minimizes this weakness.
The participants were largely white, which 
may limit generalizability to non-white popu-
lations. In addition, participants smoked an 
average of 20 cigarettes per day and, as noted 
previously, an observational study of tobacco 
users in France found that heavy smokers 
(≥21 cigarettes/d) were more likely to quit 
gradually than abruptly, so results may not be 
generalizable to heavy smokers.7
CHALLENGES TO IMPLEMENTATION
Finding the time and staff  
for considerable behavioral support
One important challenge is the implementa-
tion of such a structured tobacco cessation 
program in primary care. Both abrupt- and 
gradual-cessation groups were given con-
siderable behavioral support from research 
nurses. Participants in this study were seen 
by a nurse 7 times in the first 6 weeks of the 
study, and the intervention included nurse-
created reduction schedules. 
Even if patients in the study preferred 
one method of cessation to another, they 
were receptive to quitting either gradually 
or abruptly. In clinical practice, patients are 
often set in their desired method of cessation. 
In that setting, our role is then to inform them 
of the data and support them in whatever 
method they choose.                    JFP
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